Globus Medical (GMED) Gains from Investment Securities (2016 - 2026)

Globus Medical (GMED) has reported Gains from Investment Securities for 11 consecutive years, with $9.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gains from Investment Securities rose 85.89% year-over-year to $9.7 million; the trailing twelve-month figure through Jun 2026 stood at $24.1 million (up 25.88% YoY), and the FY2025 full-year result was $13.5 million, down 49.24% from the prior year.
• Gains from Investment Securities advanced to $9.7 million in Q2 2026 per GMED's latest filing, from $6.4 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $17.9 million in Q4 2024 and bottomed at -$4.1 million in Q3 2024.
• Historically, Gains from Investment Securities has averaged $4.4 million across 5 years, with a median of $2.4 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities slumped 458.91% in 2024, then jumped 3703.59% in 2026.
• Over 5 years, Gains from Investment Securities stood at $7.2 million in 2022, then surged by 81.23% to $13.0 million in 2023, then surged by 37.76% to $17.9 million in 2024, then tumbled by 39.74% to $10.8 million in 2025, then slipped by 10.07% to $9.7 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $9.7 million, $6.4 million, and $10.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.